Completed Access to Information Requests


  • RSS
  • Cite

Transitional Period

Federal departments are moving their web content to As a part of that process, proactive disclosure reports will become available through the Open Government portal.  During this transition, if a proactive disclosure report from a specific department is not yet available on the Open Government portal please refer to Proactive disclosure by department or agency where a copy can be found.  For any questions on this issue, please contact us at .

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests previously made to the Government of Canada. If you find a summary of interest, you can request a copy of the records at no cost. For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator.

Enter keywords (e.g. institution, topic, field of interest, etc.)
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type




Found 278 record(s)

Req # A-2019-000010

Adverse Reaction Report (AER) for SARILUMAB. Report number: E2B_01396966.

Organization: Health Canada

16 page(s)
July 2019

Req # A-2019-000326

Adverse Reaction Report (AER) for Articaine Hydrochloride. Report number: E2B_01996831.

Organization: Health Canada

6 page(s)
July 2019

Req # A-2016-000133

All calendar records for all EX category personnel with Health Canada’s Tobacco Directorate from January 1, 2010 to December 31, 2010.

Organization: Health Canada

2236 page(s)
July 2019

Req # A-2018-001915

Adverse Reaction Report (AER). Report numbers: 0007190167, 000719315, E2B_02165440, 0007197649, E2B_0214262310.

Organization: Health Canada

50 page(s)
July 2019

Req # A-2016-000329

All records for 2015-2016: violation investigations reports on pesticide companies; summary of suspended, delisted and fined pesticide companies; summary of acute pesticide poisoning incidents; surveys on pesticide use and impacts. 2016 briefing notes on concerns with pesticide use.

Organization: Health Canada

1361 page(s)
July 2019

Req # A-2016-001246

All notifiable changes relating to Actavis Pharma Company’s ACT Tadalafil product, Drug Identification Number (DINs) 02428628, 02428636, 02428644, 02428652.

Organization: Health Canada

909 page(s)
July 2019

Req # A-2018-000879

All emails from Cynthia Richardson’s outlook pertaining to Misc 2 between September 24, 2017 to October 24, 2017.

Organization: Health Canada

249 page(s)
July 2019

Req # A-2017-000510

The various versions of the research protocol for the study "A phase I/Ila Dose-Escalation Study of the Decitabine-Genistein Drug Combination in Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) Subjects". The identification number for the clinical trial is NCT01628471.

Organization: Health Canada

59 page(s)
July 2019

Req # A-2017-001754

Health Canada inspections of medical device establishments: Frappier Chevreux Medical Device Canada Inc (December 5, 2016), Cosmétiques France Laure (1970) Inc. (August 16, 2016).

Organization: Health Canada

839 page(s)
July 2019

Req # A-2017-001778

An extract (list) from your medical devices database regarding issues/malfunctions from December 30, 2016 to April 10, 2018.

Organization: Health Canada

2903 page(s)
July 2019

What's new in open government?